Government Intervention and Public Health

This chapter explores the consequences of government involvement in pharmaceutical research, particularly in the context of Europe's drug pricing and mRNA vaccine innovation. The discussion highlights the lessons learned from the pandemic, including institutional failures and the complexities of public health management amidst political influences. It also reflects on the polarized responses to health measures, comparing the U.S. and Europe while advocating for accountability and transparency in public health discourse.